Smart Patients Get Smart Care™
The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients
Immunotherapy is most broadly defined as any treatment that uses a person’s own immune system to fight cancer by boosting or changing how the immune system works so it can better find and attack cancer cells.
ASH 2019: Dr. Wiestner Discusses a Novel Way to Control CLL by Degrading BTK Rather Than Blocking It.
ASH 2019: Dr. Alexey Danilov and Dr. John Pagel discuss New Drug Targeting SYK Pathway Provides Hope When Used in Combination with Obinutuzumab
May 15, 2020 CAR-T is an essential new treatment opportunity for patients. In my personal experience, I have no measurable leukemia two years after completing my CAR-T clinical trial in Seattle.
In our ASH 2019 interview with Dr. John Pagel, we learn that PI3 kinase inhibitors are potent medications that control CLL, but their widespread adoption has been slowed by their potential side effects.
Recorded April 28, 2020 https://youtu.be/WI-kxSd6JNw Find out everything you need to know, from A – Z for those newly diagnosed with CLL, including what to watch out for, the prognostic testing
Dr. Brian Koffman’s ASH 2019 interview with Dr. Deborah Stephens in which they discuss the German CLL 12 Study, which is investigating the novel and evolving view that certain high-risk CLL patients may benefit from early intervention with ibrutinib.
At ASH 2019 Dr. Chaitra Ujjani discusses real world prescribing for CLL and why expert care is so critical.
🎶 It was 2 short years ago today, my CAR-T cells really learnt to play, They have been going in and out of glands, no guarantee that they would expand But
One click to our most popular content.
